查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
ALPHA乳清蛋白的全球市場 - 全球產業分析、規模、份額、成長、趨勢、預測 (2031) - 按應用、按地區
市場調查報告書
商品編碼
1397294

ALPHA乳清蛋白的全球市場 - 全球產業分析、規模、份額、成長、趨勢、預測 (2031) - 按應用、按地區

Alpha Lactalbumin Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)
出版日期: | 出版商: Fairfield Market Research | 英文 200 Pages | 商品交期: 2-5個工作天內

價格
簡介目錄

全球ALPHA-乳清蛋白市場規模預計將在2024年至2031年間顯著成長。 預計到 2031 年，該市場將從 2.14 億美元成長到約 3.85 億美元。

這一成長的主要驅動力是嬰兒配方奶粉市場的強勁擴張，這主要是由全球職業女性人口不斷增加所推動的。 ALPHA-乳清蛋白是人類母乳中發現的主要蛋白質，被認為含有必需胺基酸。 事實證明，將其添加到嬰兒配方奶粉中可以減少胃腸道餵食相關事件，使其成為尋求母乳替代品的母親的熱門選擇。 隨著世界勞動人口的增加，對嬰兒配方奶粉的需求不斷增加，直接拉動了對ALPHA-乳清蛋白的需求。

此外，全球加工食品市場對ALPHA-乳清蛋白市場也產生重大影響。 消費者便利性、安全性和生活方式偏好的變化導致對富含 ALPHA-乳清蛋白的加工食品的需求增加。

主要的ALPHA-乳清蛋白製造商正在透過採取各種擴張策略積極增加其市場份額。 每個製造商都致力於根據客戶要求提供客製化解決方案，同時投資研發以提高產品品質。 遵守嚴格的行業標準和法規對於製造過程至關重要。 此外，這些製造商正在提高生產能力並升級加工技術和設備，以滿足不同最終用途領域不斷增長的需求。

由於快速城市化、可支配收入增加以及西方文化對發展中國家的影響，世界對乳製品的需求正在上升。 芬蘭、丹麥、德國、冰島和法國等國家對乳酪和乳酪產品的需求激增是促進ALPHA-乳清蛋白成長的主要因素。

本報告調查了全球 ALPHA-乳清蛋白市場，並提供了市場概述以及進入市場的公司按應用、地區和競爭趨勢劃分的趨勢。

目錄

第 1 章執行摘要

第二章市場概述

  • 市場定義與細分
  • 市場動態
  • 價值鏈分析
  • 波特五力分析
  • 新冠肺炎 (COVID-19) 影響分析
  • 烏克蘭和俄羅斯之間衝突的影響
  • 經濟概況
  • PESTLE分析

第 3 章價格分析，2018-2023

第 4 章 2018-2031 年全球 ALPHA-乳清蛋白市場展望

  • 2018-2031 年全球 ALPHA-乳清蛋白市場前景（按應用、價值（百萬美元）、數量（百萬單位））
  • 2018-2031 年全球 ALPHA-乳清蛋白市場前景（按地區、價值（百萬美元）、數量（百萬單位））

第五章北美 ALPHA-乳清蛋白市場展望，2018-2031

第 6 章歐洲 ALPHA-乳清蛋白市場展望，2018-2031

第 7 章亞太地區 ALPHA-乳清蛋白市場展望，2018-2031

第 8 章拉丁美洲 ALPHA-乳清蛋白市場前景，2018-2031

第 9 章 2018-2031 年中東與非洲 ALPHA-乳清蛋白市場前景

第10章競爭態勢

  • 2023 年公司市佔率分析
  • 競爭力儀表板
  • 公司簡介
    • Arla Foods Ingredients Group P/S
    • Hilmar Ingredients
    • Milk Specialties Global
    • VWR International, LLC
    • Agropur, Inc.
    • Xuchang Shangke Chemical Co., Ltd.
    • Merck KGaA
    • Abcam PLC
    • Shanghai Korain Biotech Co., Ltd.
    • FrieslandCampina N.V.
    • Giellepi Spa
    • Novus Biologicals, Inc.

第11章附錄

簡介目錄

The global Alpha Lactalbumin market is set to experience an impressive growth trajectory during the period from 2024 to 2031. The market size is projected to increase from US$ 214 million to approximately US$ 385 million by 2031, according to a recent market study report by Fairfield Market Research.

Rising Demand Driven by Surging Infant Formula Market

The key driver of this growth is the robust expansion of the infant formula market, largely fueled by the increasing population of working women worldwide. Alpha Lactalbumin, a dominant protein in human milk, is being recognized for its essential amino acid content. Its inclusion in infant formula has been shown to reduce gastrointestinal feeding-related events, making it a popular choice for mothers seeking an alternative to breast milk. With the global workforce seeing a rising number of women, the demand for infant formula is on the rise, directly boosting the demand for alpha lactalbumin.

Processed Food Market and Lifestyle Changes Fueling Demand

Furthermore, the global processed food market is making a significant impact on the alpha lactalbumin market. The convenience, safety, and changing lifestyle preferences of consumers have led to increased demand for processed food products that often contain alpha lactalbumin.

Manufacturers Focusing on Quality and Expansion

Leading alpha lactalbumin manufacturers are actively expanding their market share by adopting various expansion strategies. They are dedicated to providing customized solutions to meet customer requirements while investing in research and development to enhance product quality. Compliance with strict industry standards and regulations is paramount in their production processes. Additionally, these manufacturers are increasing production capacity and upgrading their processing technologies and equipment to meet the growing demand from diverse end-use segments.

Rising Dairy Product Demand Boosts Alpha-Lactalbumin

The global demand for dairy products is on the rise due to rapid urbanization, increased disposable income, and the influence of Western culture in developing countries. This surge in demand for cheese and cheese products in countries such as Finland, Denmark, Germany, Iceland, and France is a major factor contributing to the growth of alpha lactalbumin.

Consumer-Centric Labeling Enhances Market Expansion

Consumer awareness about the ingredients they consume is at an all-time high. Brands in the sports nutrition industry are responding to this demand by providing detailed package information, including the origin of ingredients and sustainable farming practices. The incorporation of natural and plant-based ingredients is also a priority for these brands.

North America and European Countries Attracting Manufacturers

North America and European countries have become hubs for alpha lactalbumin manufacturers due to the increasing demand for fortified and nutritional foods in these regions. High disposable income, a preference for premium products, and growing health and wellness consciousness among consumers are driving significant opportunities for alpha lactalbumin manufacturers.

Germany Dominates the European Landscape

Germany stands out as the dominant country among European nations in the alpha lactalbumin market. The increasing demand for nutritional products, high disposable income, and a growing consumer base seeking health and wellness benefits have contributed to Germany's remarkable growth in this sector.

Competitive Landscape

Major players in the global alpha lactalbumin market, including Arla Foods Ingredients Group P/S, Hilmar Ingredients, and Milk Specialties Global, Inc., are actively expanding their presence. Their strategies involve business expansion, increased production capacity, and innovative product offerings.

Key Companies Profiled:

  • Arla Foods Ingredients Group P/S
  • Hilmar Ingredients
  • Milk Specialties Global
  • VWR International, LLC
  • Agropur, Inc.
  • Xuchang Shangke Chemical Co., Ltd.
  • Merck KGaA
  • Abcam PLC
  • Shanghai Korain Biotech Co., Ltd.
  • FrieslandCampina N.V.
  • Giellepi Spa
  • Novus Biologicals, Inc.

With a promising outlook driven by multiple factors, the alpha lactalbumin market is poised for substantial growth in the coming years. For more detailed insights, please refer to the full market study report by Fairfield Market Research.

Market Segmentation

By Application:

  • Infant Formula
  • Clinical Nutrition
  • Sports Nutrition
  • Nutraceuticals
  • Others

By Region:

  • North America
  • Latin America
  • Europe
  • South Asia & Pacific
  • East Asia
  • Middle East & Africa

Table of Contents

1. Executive Summary

  • 1.1. Global Alpha Lactalbumin Market Snapshot
  • 1.2. Future Projections
  • 1.3. Key Market Trends
  • 1.4. Regional Snapshot, by Value and Volume, 2023
  • 1.5. Analyst Recommendations

2. Market Overview

  • 2.1. Market Definitions and Segmentations
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Market Opportunities
  • 2.3. Value Chain Analysis
  • 2.4. Porter's Five Forces Analysis
  • 2.5. COVID-19 Impact Analysis
    • 2.5.1. Supply
    • 2.5.2. Demand
  • 2.6. Impact of Ukraine-Russia Conflict
  • 2.7. Economic Overview
    • 2.7.1. World Economic Projections
  • 2.8. PESTLE Analysis

3. Price Analysis, 2018 - 2023

  • 3.1. Global Average Price Analysis, by Application, US$ Per Unit, 2018 - 2023
  • 3.2. Prominent Alpha Lactalbumin Market Markers Prices
  • 3.3. Global Average Price Analysis, by Region, US$ Per Unit

4. Global Alpha Lactalbumin Market Outlook, 2018 - 2031

  • 4.1. Global Alpha Lactalbumin Market Outlook, by Application, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
    • 4.1.1. Key Highlights
      • 4.1.1.1. Infant Formula
      • 4.1.1.2. Clinical Nutrition
      • 4.1.1.3. Sports Nutrition
      • 4.1.1.4. Nutraceuticals
      • 4.1.1.5. Others
  • 4.2. Global Alpha Lactalbumin Market Outlook, by Region, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
    • 4.2.1. Key Highlights
      • 4.2.1.1. North America
      • 4.2.1.2. Europe
      • 4.2.1.3. Asia Pacific
      • 4.2.1.4. Latin America
      • 4.2.1.5. Middle East & Africa

5. North America Alpha Lactalbumin Market Outlook, 2018 - 2031

  • 5.1. North America Alpha Lactalbumin Market Outlook, by Application, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
    • 5.1.1. Key Highlights
      • 5.1.1.1. Infant Formula
      • 5.1.1.2. Clinical Nutrition
      • 5.1.1.3. Sports Nutrition
      • 5.1.1.4. Nutraceuticals
      • 5.1.1.5. Others
  • 5.2. North America Alpha Lactalbumin Market Outlook, by Country, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
    • 5.2.1. Key Highlights
      • 5.2.1.1. U.S. Alpha Lactalbumin Market by Application, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 5.2.1.2. Canada Alpha Lactalbumin Market by Application, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
    • 5.2.2. BPS Analysis/Market Attractiveness Analysis

6. Europe Alpha Lactalbumin Market Outlook, 2018 - 2031

  • 6.1. Europe Alpha Lactalbumin Market Outlook, by Application, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
    • 6.1.1. Key Highlights
      • 6.1.1.1. Infant Formula
      • 6.1.1.2. Clinical Nutrition
      • 6.1.1.3. Sports Nutrition
      • 6.1.1.4. Nutraceuticals
      • 6.1.1.5. Others
  • 6.2. Europe Alpha Lactalbumin Market Outlook, by Country, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
    • 6.2.1. Key Highlights
      • 6.2.1.1. Germany Alpha Lactalbumin Market by Application, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 6.2.1.2. U.K. Alpha Lactalbumin Market by Application, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 6.2.1.3. France Alpha Lactalbumin Market by Application, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 6.2.1.4. Italy Alpha Lactalbumin Market by Application, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 6.2.1.5. Turkey Alpha Lactalbumin Market by Application, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 6.2.1.6. Russia Alpha Lactalbumin Market by Application, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 6.2.1.7. Rest of Europe Alpha Lactalbumin Market by Application, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
    • 6.2.2. BPS Analysis/Market Attractiveness Analysis

7. Asia Pacific Alpha Lactalbumin Market Outlook, 2018 - 2031

  • 7.1. Asia Pacific Alpha Lactalbumin Market Outlook, by Application, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
    • 7.1.1. Key Highlights
      • 7.1.1.1. Infant Formula
      • 7.1.1.2. Clinical Nutrition
      • 7.1.1.3. Sports Nutrition
      • 7.1.1.4. Nutraceuticals
      • 7.1.1.5. Others
  • 7.2. Asia Pacific Alpha Lactalbumin Market Outlook, by Country, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
    • 7.2.1. Key Highlights
      • 7.2.1.1. China Alpha Lactalbumin Market by Application, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 7.2.1.2. Japan Alpha Lactalbumin Market by Application, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 7.2.1.3. South Korea Alpha Lactalbumin Market by Application, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 7.2.1.4. India Alpha Lactalbumin Market by Application, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 7.2.1.5. Southeast Asia Alpha Lactalbumin Market by Application, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 7.2.1.6. Rest of Asia Pacific Alpha Lactalbumin Market by Application, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
    • 7.2.2. BPS Analysis/Market Attractiveness Analysis

8. Latin America Alpha Lactalbumin Market Outlook, 2018 - 2031

  • 8.1. Latin America Alpha Lactalbumin Market Outlook, by Application, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
    • 8.1.1. Key Highlights
      • 8.1.1.1. Infant Formula
      • 8.1.1.2. Clinical Nutrition
      • 8.1.1.3. Sports Nutrition
      • 8.1.1.4. Nutraceuticals
      • 8.1.1.5. Others
  • 8.2. Latin America Alpha Lactalbumin Market Outlook, by Country, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
    • 8.2.1. Key Highlights
      • 8.2.1.1. Brazil Alpha Lactalbumin Market by Application, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 8.2.1.2. Mexico Alpha Lactalbumin Market by Application, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 8.2.1.3. Argentina Alpha Lactalbumin Market by Application, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 8.2.1.4. Rest of Latin America Alpha Lactalbumin Market by Application, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
    • 8.2.2. BPS Analysis/Market Attractiveness Analysis

9. Middle East & Africa Alpha Lactalbumin Market Outlook, 2018 - 2031

  • 9.1. Middle East & Africa Alpha Lactalbumin Market Outlook, by Application, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
    • 9.1.1. Key Highlights
      • 9.1.1.1. Infant Formula
      • 9.1.1.2. Clinical Nutrition
      • 9.1.1.3. Sports Nutrition
      • 9.1.1.4. Nutraceuticals
      • 9.1.1.5. Others
  • 9.2. Middle East & Africa Alpha Lactalbumin Market Outlook, by Country, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
    • 9.2.1. Key Highlights
      • 9.2.1.1. GCC Alpha Lactalbumin Market by Application, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 9.2.1.2. South Africa Alpha Lactalbumin Market by Application, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 9.2.1.3. Egypt Alpha Lactalbumin Market by Application, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 9.2.1.4. Nigeria Alpha Lactalbumin Market by Application, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 9.2.1.5. Rest of Middle East & Africa Alpha Lactalbumin Market by Application, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
    • 9.2.2. BPS Analysis/Market Attractiveness Analysis

10. Competitive Landscape

  • 10.1. Company Market Share Analysis, 2023
  • 10.2. Competitive Dashboard
  • 10.3. Company Profiles
    • 10.3.1. Arla Foods Ingredients Group P/S
      • 10.3.1.1. Company Overview
      • 10.3.1.2. Product Portfolio
      • 10.3.1.3. Financial Overview
      • 10.3.1.4. Business Strategies and Development
    • 10.3.2. Hilmar Ingredients
      • 10.3.2.1. Company Overview
      • 10.3.2.2. Product Portfolio
      • 10.3.2.3. Financial Overview
      • 10.3.2.4. Business Strategies and Development
    • 10.3.3. Milk Specialties Global
      • 10.3.3.1. Company Overview
      • 10.3.3.2. Product Portfolio
      • 10.3.3.3. Financial Overview
      • 10.3.3.4. Business Strategies and Development
    • 10.3.4. VWR International, LLC
      • 10.3.4.1. Company Overview
      • 10.3.4.2. Product Portfolio
      • 10.3.4.3. Financial Overview
      • 10.3.4.4. Business Strategies and Development
    • 10.3.5. Agropur, Inc.
      • 10.3.5.1. Company Overview
      • 10.3.5.2. Product Portfolio
      • 10.3.5.3. Financial Overview
      • 10.3.5.4. Business Strategies and Development
    • 10.3.6. Xuchang Shangke Chemical Co., Ltd.
      • 10.3.6.1. Company Overview
      • 10.3.6.2. Product Portfolio
      • 10.3.6.3. Financial Overview
      • 10.3.6.4. Business Strategies and Development
    • 10.3.7. Merck KGaA
      • 10.3.7.1. Company Overview
      • 10.3.7.2. Product Portfolio
      • 10.3.7.3. Financial Overview
      • 10.3.7.4. Business Strategies and Development
    • 10.3.8. Abcam PLC
      • 10.3.8.1. Company Overview
      • 10.3.8.2. Product Portfolio
      • 10.3.8.3. Financial Overview
      • 10.3.8.4. Business Strategies and Development
    • 10.3.9. Shanghai Korain Biotech Co., Ltd.
      • 10.3.9.1. Company Overview
      • 10.3.9.2. Product Portfolio
      • 10.3.9.3. Financial Overview
      • 10.3.9.4. Business Strategies and Development
    • 10.3.10. FrieslandCampina N.V.
      • 10.3.10.1. Company Overview
      • 10.3.10.2. Product Portfolio
      • 10.3.10.3. Financial Overview
      • 10.3.10.4. Business Strategies and Development
    • 10.3.11. Giellepi Spa
      • 10.3.11.1. Company Overview
      • 10.3.11.2. Product Portfolio
      • 10.3.11.3. Financial Overview
      • 10.3.11.4. Business Strategies and Development
    • 10.3.12. Novus Biologicals, Inc.
      • 10.3.12.1. Company Overview
      • 10.3.12.2. Product Portfolio
      • 10.3.12.3. Financial Overview
      • 10.3.12.4. Business Strategies and Development

11. Appendix

  • 11.1. Research Methodology
  • 11.2. Report Assumptions
  • 11.3. Acronyms and Abbreviations